Personal CFO Solutions’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,238	Closed	-$356K	–	553
2024 Q3	$356K	Hold	14,238	–	–	0.05%	350
2024 Q2	$266K	Hold	14,238	–	–	0.04%	425
2024 Q1	$281K	Hold	14,238	–	–	0.04%	416
2023 Q4	$250K	Hold	14,238	–	–	0.04%	423
2023 Q3	$247K	Hold	14,238	–	–	0.05%	378
2023 Q2	$200K	Hold	14,238	–	–	0.04%	447
2023 Q1	$153K	Hold	14,238	–	–	0.03%	456
2022 Q4	$213K	Hold	14,238	–	–	0.05%	404
2022 Q3	$183K	Sell	14,238 -1,000	-7%	-$11.4K	0.05%	383
2022 Q2	$148K	Sell	15,238 -2,000	-12%	-$18.7K	0.03%	409
2022 Q1	$171K	Hold	17,238	–	–	0.03%	445
2021 Q4	$203K	Sell	17,238 -5,000	-22%	-$61.4K	0.04%	442
2021 Q3	$253K	Sell	22,238 -4,300	-16%	-$56K	0.05%	352
2021 Q2	$370K	Buy	26,538 +300	+1%	+$4.56K	0.08%	236
2021 Q1	$486K	Hold	26,238	–	–	0.11%	181
2020 Q4	$464K	Buy	26,238 +4,538	+21%	+$79.7K	0.11%	177
2020 Q3	$0	Buy	21,700 +2,000	+10%	+$37.5K	﹤0.01%	245
2020 Q2	$502K	Hold	19,700	–	–	0.15%	128
2020 Q1	$305K	Buy	+19,700	New	+$308K	0.11%	169

Other funds holding KNSA